Venture Round - InteKrin
Investment Firm
Overview
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.
Announced Date
Apr 02, 2009
Funding Type
Series Unknown
Highlights
Location
United States, North America
Social
N/A
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Asset Management Company |
Round Details and Background
InteKrin raised $21391923 on 2009-04-02 in Venture Round
InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 12, 2007 |  Series B - InteKrin | 6 | - | 23.0M |
| Apr 02, 2009 | Venture Round - InteKrin | 1 | - | 21.4M |
| Jun 14, 2010 | Venture Round - InteKrin | 1 | - | 2.3M |
| Aug 04, 2008 | Series C - InteKrin | 8 | - | 18.5M |
Recent Activity
There is no recent news or activity for this profile.